CA
ADMA icon

Cliff Asness’s ADMA Biologics ADMA Stock Holding History

Cliff Asness’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8M Buy
1,525,581
+1,010,792
+196% +$9.21M ﹤0.01% 1416
2026
Q1 		$4.64M Buy
514,789
+208,582
+68% +$3.29M ﹤0.01% 1803
2025
Q4 		$5.59M Buy
306,207
+31,048
+11% +$523K ﹤0.01% 1515
2025
Q3 		$4.03M Sell
275,159
-184,722
-40% -$3.17M ﹤0.01% 1579
2025
Q2 		$8.37M Sell
459,881
-60,007
-12% -$1.22M 0.01% 1043
2025
Q1 		$10.3M Sell
519,888
-10,280
-2% -$178K 0.01% 863
2024
Q4 		$9.09M Sell
530,168
-59,145
-10% -$1.11M 0.01% 853
2024
Q3 		$11.8M Sell
589,313
-184,093
-24% -$2.86M 0.02% 759
2024
Q2 		$8.65M Sell
773,406
-43,547
-5% -$365K 0.01% 805
2024
Q1 		$5.39M Buy
816,953
+225,750
+38% +$1.23M 0.01% 953
2023
Q4 		$2.67M Buy
591,203
+49,160
+9% +$182K 0.01% 1220
2023
Q3 		$1.94M Buy
542,043
+90,236
+20% +$347K ﹤0.01% 1338
2023
Q2 		$1.67M Buy
451,807
+312,493
+224% +$1.16M ﹤0.01% 1339
2023
Q1 		$461K Buy
139,314
+16,463
+13% +$56.9K ﹤0.01% 1807
2022
Q4 		$477K Buy
122,851
+48,655
+66% +$150K ﹤0.01% 1834
2022
Q3 		$180K Buy
+74,196
New +$178K ﹤0.01% 2055
2020
Q3 		– Sell
-29,215
Closed -$86K – 2171
2020
Q2 		$86K Buy
+29,215
New +$83.9K ﹤0.01% 2066

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Cliff Asness's ADMA Position: Q2 2026 in Review

Cliff Asness increased its ADMA Biologics (ADMA) stake by 196% in Q2 2026, buying an estimated $9.21M and bringing the position to 1,525,581 shares worth $12.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Cliff Asness first reported a position in ADMA in Q2 2020 and has held it in 17 quarters since. 321 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Cliff Asness held 1,525,581 shares of ADMA Biologics worth $12.8M as of Q2 2026.
  • Cliff Asness bought 1,010,792 ADMA Biologics shares in Q2 2026, an estimated $9.21M.
  • ADMA Biologics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1416 holding.
  • Cliff Asness first reported a position in ADMA Biologics in Q2 2020 and has held it in 17 quarters since.
  • 321 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.